Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: After reading most of the Q ...

There is nothing this company should be focused on besides the MMP. The fact that they essentially gave away control of the MMP doesn't change that. Getting restless and spending crucial cash reserves on various wild goose chases may very well be the downfall of PTSC. The fact that they went on this spending spree at the top of the most recent bubble certainly gives us a good measure of the market savvy of the BoD and their hires.

This is a dreadful company with a patent full of potential. And they're doing their best to squander it. Is PTSC really this inept or is it something else?

I'm pretty sure I've always stated on this board that PDSG is a diversion and any attempts at M&A by Patriot are futile.

This Quarterly is the result of many chickens coming home to roost. Chickens that many Agora posters pointed out but were called "bashers" or "haters" and shouted down for calling attention to.

Oh, and in classic PTSC fashion, I expect the short term PPS action to be baffling after this report.

Share
New Message
Please login to post a reply